Genome Diagnostics, cancer-test maker, aims for $1.6M

November 28, 2007 | David P. Hamilton | Comments | |

See our story on this Pasadena, Calif., developer of cancer tests supposedly based on whole-genome sequencing in today’s daily briefing at VentureBeat Life Sciences.

Next Story: Electric car company Tesla appoints new CEO
Previous Story: Roundup: CondéNet, Disney, Google, and more

Bookmark and Share

Photo of David P. Hamilton

About the Author, David P. Hamilton

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.